Prostate Test Ads Banned for Misleading Claims

Regulators have banned six online advertisements promoting at-home prostate cancer tests and supplements, deeming them potentially misleading to vulnerable consumers. The Advertising Standards Authority (ASA) found that several companies made unsubstantiated medical claims for their products. Four supplement brands advertised treatments for enlarged prostate and urinary problems, despite their products not being authorized medicines.

Additionally, two companies selling prostate home-testing kits were found to have advertised Prostate-Specific Antigen (PSA) tests as diagnostic tools. The ASA clarified that PSA tests alone cannot diagnose or rule out prostate cancer; they are merely an initial step in identifying potential issues. One ad even suggested consumers could 'skip the doctors,' which the ASA interpreted as a misleading claim about the test's reliability.

The ASA has instructed the banned companies to cease making medicinal claims for unauthorized products or health claims for food products. Regulatory bodies emphasize that while at-home tests can monitor prostate health, they are not definitive for cancer diagnosis, and consumers should always consult healthcare professionals for accurate medical advice.